Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18507665 | 0.71 | ALDH1A1 (0.34) | — | |
| Hexane SCHEMBL28120182 | 0.69 | CYP2C19 (0.48) | CA1 | |
| Heptane SCHEMBL28923213 | 0.67 | CYP2C19 (0.46) | — | |
| SCHEMBL25516869 | 0.62 | OPRM1 (0.37) | — | |
| SCHEMBL11230782 | 0.61 | GAA (0.36) | — | |
| Butane SCHEMBL5614872 | 0.61 | CYP2C19 (0.52) | — | |
| SCHEMBL2092642 | 0.60 | KMT2A (0.52) | — | |
| SCHEMBL1170387 | 0.60 | CA1 (0.45) | CA1 | |
| SCHEMBL28480389 | 0.60 | ACE2 (0.55) | CA1 | |
| SCHEMBL24486062 | 0.60 | FDPS (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170066716-A1 | ENERGETIC N-SUBSTITUTED 3, 3-DINITROAZETIDINE PLASTICIZER AND PREPARATION METHOD THEREOF | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2017-03-09 | — | — | US | disclosed |
| US-20170066716-A1 | ENERGETIC N-SUBSTITUTED 3, 3-DINITROAZETIDINE PLASTICIZER AND PREPARATION METHOD THEREOF | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2017-03-09 | — | — | US | disclosed |
| US-20170066716-A1 | ENERGETIC N-SUBSTITUTED 3, 3-DINITROAZETIDINE PLASTICIZER AND PREPARATION METHOD THEREOF | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2017-03-09 | — | — | US | disclosed |
| US-9573894-B1 | Energetic N-substituted 3, 3-dinitroazetidine plasticizer and preparation method thereof | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2017-02-21 | — | — | US | disclosed |
| US-9573894-B1 | Energetic N-substituted 3, 3-dinitroazetidine plasticizer and preparation method thereof | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2017-02-21 | — | — | US | disclosed |
| US-9573894-B1 | Energetic N-substituted 3, 3-dinitroazetidine plasticizer and preparation method thereof | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2017-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170066716-A1 | ENERGETIC N-SUBSTITUTED 3, 3-DINITROAZETIDINE PLASTICIZER AND PREPARATION METHOD THEREOF | NFE2L2, NQO1, NBAS | CA1 4688/4885PKM 3321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.